85 related articles for article (PubMed ID: 21566941)
1. Phorbol 12-myristate 13-acetate (pma) induces neuroendocrine-like differentiation and reverses Doxorubicin-resistance of human colon-carcinoma cells in-vitro.
Correale P; Caraglia M; Pepe S; Ricciardi B; Barile C; Montagnani S; Pacelli R; Bianco A; Tagliaferri P
Int J Oncol; 1994 Feb; 4(2):423-7. PubMed ID: 21566941
[TBL] [Abstract][Full Text] [Related]
2. Modulation of multidrug resistance by verapamil or mdr1 anti-sense oligodeoxynucleotide does not change the high susceptibility to lymphokine-activated killers in mdr-resistant human carcinoma (LoVo) line.
Rivoltini L; Colombo MP; Supino R; Ballinari D; Tsuruo T; Parmiani G
Int J Cancer; 1990 Oct; 46(4):727-32. PubMed ID: 1976601
[TBL] [Abstract][Full Text] [Related]
3. Intracellular P-glycoprotein expression is associated with the intrinsic multidrug resistance phenotype in human colon adenocarcinoma cells.
Meschini S; Calcabrini A; Monti E; Del Bufalo D; Stringaro A; Dolfini E; Arancia G
Int J Cancer; 2000 Sep; 87(5):615-28. PubMed ID: 10925353
[TBL] [Abstract][Full Text] [Related]
4. Reversal of doxorubicin resistance by the amiloride analogue EIPA in multidrug resistant human colon carcinoma cells.
Pannocchia A; Revelli S; Tamponi G; Giorgianni A; Todde R; Bosia A; Ghigo D
Cell Biochem Funct; 1996 Mar; 14(1):11-8. PubMed ID: 8907249
[TBL] [Abstract][Full Text] [Related]
5. Reversal of adriamycin resistance by recombinant alpha-interferon in multidrug-resistant human colon carcinoma LoVo-doxorubicin cells.
Scala S; Pacelli R; Iaffaioli RV; Normanno N; Pepe S; Frasci G; Genua G; Tsuruo T; Tagliaferri P; Bianco AR
Cancer Res; 1991 Sep; 51(18):4898-902. PubMed ID: 1893380
[TBL] [Abstract][Full Text] [Related]
6. Doxorubicin induces the acetylation of histone H1 in a human colon cancer cell line (LoVo/DX) selected for resistance to the drug, but not in the sensitive parental line (LoVo).
Mannironi C; D'Incalci M
Biochem Biophys Res Commun; 1988 Sep; 155(3):1221-9. PubMed ID: 3178805
[TBL] [Abstract][Full Text] [Related]
7. Effect of pO2 on antitumor drug cytotoxicity on MDR and non-MDR variants selected from the LoVo metastatic colon carcinoma cell line.
Lelong-Rebel I; Brisson C; Fabre M; Bergerat JP; Rebel G
Anticancer Res; 2008; 28(1A):55-68. PubMed ID: 18383825
[TBL] [Abstract][Full Text] [Related]
8. Different vimentin expression in two clones derived from a human colocarcinoma cell line (LoVo) showing different sensitivity to doxorubicin.
Conforti G; Codegoni AM; Scanziani E; Dolfini E; Dasdia T; Calza M; Caniatti M; Broggini M
Br J Cancer; 1995 Mar; 71(3):505-11. PubMed ID: 7880731
[TBL] [Abstract][Full Text] [Related]
9. Na+/H+ exchanger activity is increased in doxorubicin-resistant human colon cancer cells and its modulation modifies the sensitivity of the cells to doxorubicin.
Miraglia E; Viarisio D; Riganti C; Costamagna C; Ghigo D; Bosia A
Int J Cancer; 2005 Jul; 115(6):924-9. PubMed ID: 15729714
[TBL] [Abstract][Full Text] [Related]
10. Effect of phorbol 12-myristate 13-acetate on function and gene expression of P-glycoprotein in adriamycin-resistant K562/ADM cells.
Li Y; Bi H; Zhong G; Huang L; Li G; Xia Y; Chen X; Huang M
Pharmacology; 2013; 92(3-4):121-30. PubMed ID: 24008321
[TBL] [Abstract][Full Text] [Related]
11. Medroxyprogesterone-acetate reverses the MDR phenotype of the CG5-doxorubicin resistant human breast cancer cell line.
Zibera C; Gibelli N; Maestri L; Della Cuna GR
Anticancer Res; 1995; 15(3):745-9. PubMed ID: 7645952
[TBL] [Abstract][Full Text] [Related]
12. Effect of protein kinase C on multidrug resistance of multidrug-resistant colorectal cancer LoVo/Adr cells.
Ma Q; Zhang ZS; Zhang YL; Wang QY; Lai ZS
Di Yi Jun Yi Da Xue Xue Bao; 2002 Jul; 22(7):626-8. PubMed ID: 12376294
[TBL] [Abstract][Full Text] [Related]
13. 8-Prenylnaringenin is an inhibitor of multidrug resistance-associated transporters, P-glycoprotein and MRP1.
Wesołowska O; Wiśniewski J; Sroda K; Krawczenko A; Bielawska-Pohl A; Paprocka M; Duś D; Michalak K
Eur J Pharmacol; 2010 Oct; 644(1-3):32-40. PubMed ID: 20633549
[TBL] [Abstract][Full Text] [Related]
14. Nimodipine as a modulator of resistance to doxorubicin in human colon-adenocarcinoma cells.
Bearzatto A; Saino A; Zaffaroni N; Costa A; Santi S
Int J Oncol; 1996 Jul; 9(1):57-63. PubMed ID: 21541481
[TBL] [Abstract][Full Text] [Related]
15. Flunarizine as a modulator of doxorubicin resistance in human colon-adenocarcinoma cells.
Silvestrini R; Zaffaroni N; Costa A; Orlandi L; Villa R; Hendriks HR
Int J Cancer; 1993 Oct; 55(4):636-9. PubMed ID: 8406992
[TBL] [Abstract][Full Text] [Related]
16. Multidrug resistance reversal and apoptosis induction in human colon cancer cells by some flavonoids present in citrus plants.
Wesołowska O; Wiśniewski J; Sroda-Pomianek K; Bielawska-Pohl A; Paprocka M; Duś D; Duarte N; Ferreira MJ; Michalak K
J Nat Prod; 2012 Nov; 75(11):1896-902. PubMed ID: 23137376
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of protein glycosylation reverses the MDR phenotype of cancer cell lines.
Wojtowicz K; Januchowski R; Nowicki M; Zabel M
Biomed Pharmacother; 2015 Aug; 74():49-56. PubMed ID: 26349962
[TBL] [Abstract][Full Text] [Related]
18. Characterization of a clonal human colon adenocarcinoma line intrinsically resistant to doxorubicin.
Dolfini E; Dasdia T; Arancia G; Molinari A; Calcabrini A; Scheper RJ; Flens MJ; Gariboldi MB; Monti E
Br J Cancer; 1997; 76(1):67-76. PubMed ID: 9218735
[TBL] [Abstract][Full Text] [Related]
19. Intracellular P-glycoprotein in multidrug resistant tumor cells.
Arancia G; Molinari A; Calcabrini A; Meschini S; Cianfriglia M
Ital J Anat Embryol; 2001; 106(2 Suppl 1):59-68. PubMed ID: 11729998
[TBL] [Abstract][Full Text] [Related]
20. Euphorbia Species-derived Diterpenes and Coumarins as Multidrug Resistance Modulators in Human Colon Carcinoma Cells.
Wiśniewski J; Wesołowska O; Środa-Pomianek K; Paprocka M; Bielawska-Pohl A; Krawczenko A; Duarte N; Ferreira MJ; Duś D; Michalak K
Anticancer Res; 2016 May; 36(5):2259-64. PubMed ID: 27127131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
